查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715686

自动注射器市场按成分、类型、给药方式、分销管道、治疗用途和最终用途划分－2025 年至 2030 年全球预测

Auto-Injectors Market by Component, Type, Mode of Administration, Distribution Channel, Therapeutic Use, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年自动注射器市场价值将达到 10.1 亿美元，2025 年将成长至 11 亿美元，到 2030 年将达到 17.2 亿美元，复合年增长率为 9.22%。

主要市场统计数据
基准年2024年 10.1亿美元
预计2025年 11亿美元
预测年份 2030 17.2亿美元
复合年增长率（%） 9.22%

自动注射器已成为现代医疗保健的关键技术，改变了药物管理的准确性、安全性和有效性。本执行摘要探讨了自动注射器的发展及其在各个治疗领域日益增长的重要性。近年来，设备工程和生物技术的快速发展使自动注射器从简单的输送机制升级为复杂的工具，可确保提高患者的依从性和改善临床结果。技术创新，加上对快速且易于使用的药物管理日益增长的需求，正在推动这些设备的开发和采用的成长。

在这种动态的情况下，製造商不断创新，整合提高易用性和可靠性的功能，扩大急性和慢性护理环境中可用的治疗选择。市场不仅将受益于这些技术进步，还将受益于对安全通讯协定和成本效益的更多关注。随着临床、製造和监管领域的相关人员聚集在自动注射器市场，该行业的生产标准、分销策​​略和最终用户整合正在发生重大变化。

这项全面的概述为决策者和专业人士提供了重要的见解，帮助他们了解推动自动注射器领域成长的变革趋势和微妙的市场动态。

不断变化的情况：拥抱变化与创新

近年来，在技术突破、不断变化的患者需求和动态的法规环境的推动下，自动注射器市场发生了变革性的变化。製造商正在使用尖端材料和设计技术，不仅使设备更加耐用，而且大大改善了用户体验。随着医疗保健生态系统变得越来越以患者为中心，自动注射器的设计越来越多地用于在紧急和常规护理中提供快速、可靠和直观的结果。

市场领导者正在利用数位整合并融入智慧功能，实现即时监控、数据分析以及与更广泛的医疗保健系统的连接。这种演变，特别是在改进安全通讯协定和精确剂量机制方面的演变，已经获得了临床医生和最终用户的支持。同时，监管机构正在製定更严格的标准，鼓励创新，同时确保产品安全，为下一代高品质自动注射器的蓬勃发展创造环境。

这种转变是由于人们越来越重视医疗服务的分散化，病人要求个人化、便利的照护。先进的感测器技术与人体工学设计原理的结合不断推动设备性能的提升。随着传统护理模式的发展，自动注射器的适应性和扩充性使其成为现代治疗模式的前沿，最终改变了患者的参与度和治疗结果。

洞察关键细分市场 了解自动注射器市场的不同组成部分

对汽车注射器市场的详细研究表明，在几个关键维度上存在显着的细分，每个维度都对整个行业的成长和创新做出了独特的贡献。基于组件的深刻分析表明，市场已经对激活按钮、注射针、笔盖、预载弹簧和主要药物容器进行了细緻的研究。这种方法可以详细了解产品的机械复杂性及其演变，以适应增强的性能和安全措施。

根据产品类型进行进一步细分以及一次性和可重复使用仪器之间的区分可以揭示消费者偏好和生命週期管理。这种区别在该行业的定价策略和永续性考虑中发挥着重要作用。此外，按给药方式（特别是肌肉注射与皮下注射）进行细分，可以深入了解自动注射器的治疗适应症，并使设备功能与临床要求相符。

分销管道也适合进行細項分析，线下与线上零售框架凸显了消费行为和市场进入的变化。在认可治疗用途的地方，市场可分为慢性、急性和预防保健部分，每个部分都需要自己独特的监管和製定方法。最后，基于最终用途的评估区分居家医疗环境和医院/诊所，强调决定这些设备的部署和管理的操作的多样性。综合起来，这些细分提供了对市场动态的详细了解，并可以帮助相关人员进行策略决策，以优化产品系列和市场进入。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病和文明病的全球流行
      • 家庭和紧急护理解决方案的需求增加
    • 限制因素
      • 严格的监管合规和漫长的核准流程
    • 机会
      • 开发整合数据分析的自动注射器，用于个人化治疗方法
      • 自动注射器在运动医学和紧急应变场景中的应用日益广泛
    • 任务
      • 自动注射器处置的环境问题
  • 市场区隔分析
    • 类型：在紧急和急性护理环境中，使用一次性自动注射器的趋势
    • 治疗用途：扩大自动注射器在紧急护理中的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 自动注射器市场（按组件）

  • 启动按钮
  • 针
  • 笔盖
  • 预紧弹簧
  • 主要药品容器

7. 自动注射器市场（按类型）

  • 一次性的
  • 可重复使用的

8. 自动注射器市场（依给药方式）

  • 肌肉注射
  • 皮下

第九章自动注射器市场（依通路）

  • 线下零售
  • 网路零售

第 10 章 自动注射器市场（依治疗应用）

  • 慢性治疗
  • 紧急治疗
  • 预防性治疗

第 11 章自动注射器市场：依最终用途

  • 居家照护环境
  • 医院和诊所

12. 美洲自动注射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区自动注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲自动注射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • Aktiv Medical Systems
  • Amgen Inc.
  • Amneal Pharmaceuticals, Inc.
  • AptarGroup, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Eli Lilly and Company
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Halozyme Therapeutics, Inc.
  • Johnson & Johnson Services, Inc.
  • Medeca Pharma AB
  • Merck KGaA
  • Mylan NV by Viatris Inc.
  • NEMERA Group
  • Novartis AG
  • Pfizer, Inc.
  • Ravimed Sp. z oo
  • Recipharm AB
  • Sanofi SA
  • SHL Medical AG
  • Stevanato Group
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Product Code: MRR-ED54C46E91DD

The Auto-Injectors Market was valued at USD 1.01 billion in 2024 and is projected to grow to USD 1.10 billion in 2025, with a CAGR of 9.22%, reaching USD 1.72 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.01 billion
Estimated Year [2025] USD 1.10 billion
Forecast Year [2030] USD 1.72 billion
CAGR (%) 9.22%

Auto-injectors have emerged as a pivotal technology in modern healthcare, transforming the administration of medications with precision, safety, and efficiency. This executive summary explores the evolution of auto-injectors and their growing significance across various therapeutic disciplines. Over recent years, rapid advancements in device engineering and biotechnology have elevated auto-injectors from simple delivery mechanisms to sophisticated tools that ensure better patient compliance and improved clinical outcomes. Technological innovations, coupled with an increasing demand for rapid and user-friendly drug administration, have spurred growth in both the development and adoption of these devices.

In this dynamic landscape, manufacturers continue to innovate by integrating features that enhance usability and reliability, thereby broadening the scope of treatment options available in both emergency and chronic care settings. The market not only benefits from these technological advances but also from a heightened focus on safety protocols and cost efficiency. As stakeholders from clinical, manufacturing, and regulatory spheres converge on the auto-injectors market, the industry is witnessing significant shifts in production standards, distribution strategies, and end-user integration.

This comprehensive overview provides insights that are essential for decision-makers and experts seeking to understand both the transformative trends and nuanced market dynamics driving growth in the auto-injectors domain.

Transformative Shifts in the Landscape: Embracing Change and Innovation

In recent years, the auto-injectors market has experienced transformative shifts driven by technological breakthroughs, evolving patient needs, and dynamic regulatory environments. Manufacturers have adopted cutting-edge materials and design methodologies that not only enhance device durability but also significantly improve user experience. As the healthcare ecosystem becomes more patient-centric, auto-injectors are increasingly engineered to provide rapid, reliable, and intuitive results during emergencies and routine treatments alike.

Market leaders are capitalizing on digital integration, incorporating smart features that enable real-time monitoring, data analytics, and connectivity with broader health management systems. This evolution is particularly evident in improved safety protocols and precise dosing mechanisms, which have garnered support from both clinical practitioners and end users. Concurrently, regulatory bodies are establishing more rigorous standards that encourage innovation while ensuring product safety, thus creating an environment where high-quality, next-generation auto-injectors can thrive.

These shifts are fueled by a growing emphasis on decentralizing healthcare delivery, where patients seek personalized and accessible care. The convergence of advanced sensor technologies with ergonomic design principles continues to drive enhancements in device performance. As traditional therapeutic models evolve, the adaptability and scalability of auto-injectors position them at the forefront of modern treatment paradigms, ultimately transforming patient engagement and outcomes.

Key Segmentation Insights: Understanding the Diverse Components of the Auto-Injectors Market

A detailed examination of the auto-injectors market reveals significant segmentation across several key dimensions, each contributing uniquely to the industry's overall growth and innovation. An insightful analysis based on components illustrates that the market is meticulously studied across the activation button, needle, pen cap, pre-loaded spring, and primary drug container. This approach enables a closer inspection of the product's mechanical intricacies and its evolution to accommodate enhanced performance and safety measures.

Further segmentation based on product type, distinguishing between disposable and reusable devices, sheds light on consumer preferences and lifecycle management. This distinction plays a crucial role in both pricing strategies and sustainability considerations within the sector. In addition, the differentiation by mode of administration-specifically intramuscular and subcutaneous-provides critical insights into the therapeutic adaptability of auto-injectors, aligning device functionality with clinical requirements.

Distribution channels also inform segmentation analysis, with offline and online retail frameworks highlighting shifts in consumer behavior and market access. When therapeutic use is recognized, the market is broken down into chronic treatment, emergency treatment, and preventive treatment segments, each demanding unique regulatory and formulation approaches. Finally, an evaluation based on end use differentiates between homecare settings and hospitals and clinics, underscoring the operational diversity that dictates the deployment and management of these devices. Collectively, these segmentation insights provide a granular understanding of market trends and support strategic decision-making for stakeholders aspiring to optimize product portfolios and market reach.

Based on Component, market is studied across Activation Button, Needle, Pen Cap, Pre-Loaded Spring, and Primary Drug Container.

Based on Type, market is studied across Disposable and Reusable.

Based on Mode of Administration, market is studied across Intramuscular and Subcutaneous.

Based on Distribution Channel, market is studied across Offline Retail and Online Retail.

Based on Therapeutic Use, market is studied across Chronic Treatment, Emergency Treatment, and Preventive Treatment.

Based on End Use, market is studied across Homecare Settings and Hospitals & Clinics.

Key Regional Insights: Geographic Dynamics Shaping the Auto-Injectors Market

The auto-injectors market exhibits distinct regional characteristics that influence both growth trajectories and competitive strategies. In the Americas, robust investments in healthcare infrastructure, coupled with a proactive regulatory framework, are driving the rapid adoption of auto-injectors in both emergency and chronic care scenarios. This region benefits from high-end technology integration and a strong emphasis on patient-centric solutions, ensuring that innovations translate effectively into clinical practice.

Across Europe, the Middle East, and Africa, stringent regulatory environments and a diverse demographic landscape foster a unique market scenario. This region is witnessing accelerated digital transformations, combined with increasing funding for research and development, which ultimately supports the adoption of advanced auto-injector technologies. These areas are also characterized by a balanced mix of public and private healthcare investments, which catalyze product standardization and increased market penetration.

In the rapidly expanding Asia-Pacific market, the surge in population dynamics, improvements in health literacy, and escalating healthcare expenditures actively contribute to a burgeoning demand for auto-injector devices. The region's growth is also propelled by innovative distribution networks and an increasing focus on preventive healthcare. These regional insights collectively underscore the importance of tailoring business strategies to meet localized demands and regulatory imperatives, ensuring that technological advancements align with broader regional healthcare outcomes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights: Leading Players Steering Market Evolution

The auto-injectors landscape is influenced by a spectrum of key industry players whose strategic initiatives and innovative product offerings continue to set benchmarks for excellence. Prominent organizations such as AbbVie Inc. and Amgen Inc. have consistently demonstrated a commitment to research and development, ensuring that their products remain at the cutting edge of technology. Companies like Aktiv Medical Systems and Amneal Pharmaceuticals, Inc. have also contributed significantly by refining product ergonomics and efficiency, making auto-injectors increasingly reliable for both emergency applications and ongoing therapies.

Major players including AptarGroup, Inc., Bayer AG, and Becton, Dickinson and Company have broadened their market presence by leveraging their extensive distribution networks and capitalizing on emerging market trends. The competitive landscape is further enriched by the contributions of Biogen Inc., Eli Lilly and Company, and Gerresheimer AG, each of which brings unique insights into process optimization and patient safety enhancements. Other influential corporations such as GlaxoSmithKline PLC and Halozyme Therapeutics, Inc. continue to push the envelope, pioneering novel approaches to drug delivery mechanisms.

Furthermore, industry giants like Johnson & Johnson Services, Inc., Medeca Pharma AB, and Merck KGaA are recognized for their strategic advancements in innovation and cross-functional collaborations. The progressive moves by Mylan N.V. by Viatris Inc., NEMERA Group, and Novartis AG have established benchmarks in market performance, while Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, and Sanofi S.A. reinforce the importance of quality assurance and regulatory compliance. Emerging leaders including SHL Medical AG, Stevanato Group, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Holding AG are rapidly carving out a niche for themselves, underscoring the dynamic and competitive nature of this market segment.

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aktiv Medical Systems, Amgen Inc., Amneal Pharmaceuticals, Inc., AptarGroup, Inc., Bayer AG, Becton, Dickinson and Company, Biogen Inc., Eli Lilly and Company, Gerresheimer AG, GlaxoSmithKline PLC, Halozyme Therapeutics, Inc., Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Holding AG. Actionable Recommendations for Industry Leaders: Strategies to Sustain Market Leadership

Industry leaders must adopt a multi-pronged approach to continue fostering innovation and maintaining a competitive edge in the auto-injectors market. Investment in research and development, particularly in the areas of device miniaturization, digital connectivity, and sustainability, is crucial. Companies are advised to enhance collaboration with academic institutions and research centers to foster technological breakthroughs and accelerate product refinement.

Additionally, adopting agile regulatory strategies that align with emerging standards and market expectations can facilitate smoother market entry and product launches. Cross-functional integration of insights from both clinical end-users and engineering teams allows for the design of user-friendly devices that ensure safety and efficacy. Embracing digital transformation through innovative digital marketing and e-commerce initiatives will further enhance market penetration and consumer engagement, ultimately driving profitability and brand loyalty.

Strategic partnerships, both domestic and international, can also play a pivotal role in expanding market reach and fostering local adaptability. By aligning operational strategies with evolving patient needs and technological opportunities, leaders can set a robust foundation for sustained success in a rapidly evolving market landscape.

Conclusion: Synthesizing Insights and Charting Future Trajectories

In summary, the auto-injectors market is undergoing significant transitions as technological innovations, rigorous regulatory frameworks, and evolving patient dynamics reshape the industry. The integration of advanced components and the focus on user-centric design have collectively propelled the market into a new era characterized by enhanced safety, precision, and operational efficiency. By delving deep into the segmentation based on product components, administration modes, and distribution channels, stakeholders are better equipped to navigate the competitive landscape.

Regional insights reveal a diversified market with distinct growth drivers in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions. Meanwhile, the strategic maneuvers of key industry players underscore the importance of constant innovation and quality assurance in securing market leadership. Overall, these insights coalesce to form a comprehensive picture of the industry's current state and future possibilities, providing a reliable roadmap for both established professionals and emerging market entrants.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and lifestyle diseases globally
      • 5.1.1.2. Growing demand for at-home and emergency treatment solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory compliance and lengthy approval processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of auto-injectors with integrated data analytics for personalized treatment approaches
      • 5.1.3.2. Expanding adoption of auto-injectors in sports medicine and emergency response scenarios
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental concerns over disposal of auto-injectors
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for disposable auto-injectors in emergency and acute care settings
    • 5.2.2. Therapeutic Use: Expanding utilization of auto-injectors in emergency treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Auto-Injectors Market, by Component

  • 6.1. Introduction
  • 6.2. Activation Button
  • 6.3. Needle
  • 6.4. Pen Cap
  • 6.5. Pre-Loaded Spring
  • 6.6. Primary Drug Container

7. Auto-Injectors Market, by Type

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Auto-Injectors Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Intramuscular
  • 8.3. Subcutaneous

9. Auto-Injectors Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Retail
  • 9.3. Online Retail

10. Auto-Injectors Market, by Therapeutic Use

  • 10.1. Introduction
  • 10.2. Chronic Treatment
  • 10.3. Emergency Treatment
  • 10.4. Preventive Treatment

11. Auto-Injectors Market, by End Use

  • 11.1. Introduction
  • 11.2. Homecare Settings
  • 11.3. Hospitals & Clinics

12. Americas Auto-Injectors Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Auto-Injectors Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Auto-Injectors Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Aktiv Medical Systems partners with a global pharmaceutical company to innovate a high-concentration autoinjector solution using its PenPal platform
    • 15.3.2. Nemera launches a reusable auto-injector platform at CPHI Milan to improve patient adherence and accelerate time-to-market in parenteral drug delivery
    • 15.3.3. FDA approval of Zurnai nalmefene auto-injector advances rapid emergency responses and harm reduction strategies
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aktiv Medical Systems
  • 3. Amgen Inc.
  • 4. Amneal Pharmaceuticals, Inc.
  • 5. AptarGroup, Inc.
  • 6. Bayer AG
  • 7. Becton, Dickinson and Company
  • 8. Biogen Inc.
  • 9. Eli Lilly and Company
  • 10. Gerresheimer AG
  • 11. GlaxoSmithKline PLC
  • 12. Halozyme Therapeutics, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Medeca Pharma AB
  • 15. Merck KGaA
  • 16. Mylan N.V. by Viatris Inc.
  • 17. NEMERA Group
  • 18. Novartis AG
  • 19. Pfizer, Inc.
  • 20. Ravimed Sp. z o.o.
  • 21. Recipharm AB
  • 22. Sanofi S.A.
  • 23. SHL Medical AG
  • 24. Stevanato Group
  • 25. Teva Pharmaceutical Industries Ltd.
  • 26. West Pharmaceutical Services, Inc.
  • 27. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. AUTO-INJECTORS MARKET MULTI-CURRENCY
  • FIGURE 2. AUTO-INJECTORS MARKET MULTI-LANGUAGE
  • FIGURE 3. AUTO-INJECTORS MARKET RESEARCH PROCESS
  • FIGURE 4. AUTO-INJECTORS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTO-INJECTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ACTIVATION BUTTON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PEN CAP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRE-LOADED SPRING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRIMARY DRUG CONTAINER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CHRONIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMERGENCY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREVENTIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 279. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 280. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2024